Atlas Trials

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer(CONTROL-01)

Clinical trial NCT06647680 · RECRUITING

Trial details

NCT number
NCT06647680
Sponsor
The Affiliated Hospital of Qingdao University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Rectal Cancer Patients
Start date
2025-06-01
Primary completion
2026-12-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.